N | 364 |
---|---|
Mean age, years (SD) | 60.9 (13.5) |
Male (%) | 78.6 |
Hypertension (%) | 51.4 |
Diabetes (%) | 28.9 |
Dyslipidemia (%) | 48.9 |
Current smoking (%) | 11.8 |
Prior angina (%) | 14.3 |
Prior myocardial infarction (%) | 41.2 |
Prior stroke (%) | 8.0 |
Prior heart failure (%) | 39.6 |
Prior cardiac arrest (%) | 11.6 |
Prior PCI (%) | 21.2 |
Prior CABG (%) | 16.5 |
Chronic kidney disease (%) | 4.9 |
Primary prevention indication (%) | 61.0 |
Ischemic heart disease (%) | 57.4 |
Dilated cardiomyopathy (%) | 25.0 |
Hypertrophic cardiomyopathy (%) | 3.8 |
Myocarditis (%) | 3.3 |
Sarcoidosis (%) | 3.0 |
Other cardiomyopathy (%) | 9.6 |
Cardiovascular medications (%) | |
   Aspirin | 55.7 |
   Anticoagulant | 27.8 |
   ADP receptor inhibitor | 15.9 |
   Diuretic | 44.0 |
   Beta-blocker | 82.3 |
   ACEi | 64.4 |
   ARB | 11.4 |
   Statin | 64.9 |
 Antiarrhythmic | 16.2 |
   Amiodarone | 12.8 |
   Other | 3.4 |
CMR parameters, mean (SD) | |
   LVEDVI, mL/m2 | 140.0 (45.4) |
   LVESVI, mL/m2 | 99.3 (45.4) |
   LVMI, g/m2 | 70.6 (19.0) |
   LVEF, % | 32.1 (13.8) |
   GLS, % | − 9.0 (4.3) |
   GCS, % | − 9.9 (5.0) |
   GRS, % | 19.9 (12.0) |